Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
advances in neurology
adverse drug reaction
aggrenox
algorithm
anemia
anemia, aplastic
aneurysm, berry
anticoagulant, complications of
anticoagulant, contraindications
anticoagulant, discontinuation
anticoagulant, treatment
anticoagulant, treatment in CVD
anticoagulant, treatment, combined
antihypertensive
aorta, atherosclerosis
aortic arch ulcerated plaques
aphasia
apixaban
aspirin
aspirin, dose of
aspirin, failure of
aspirin, rectal
aspirin, sex difference in antithrombotic effect
atrial fibrillation
atrial fibrillation, risk stratification
blacks
bleeding disorder
blood pressure, control
bruising
carotid artery atherosclerosis
carotid artery disease
carotid artery disease, medical management
carotid artery stenosis
carotid artery stenosis, intracranial
carotid artery stenosis, risk of stroke with
carotid artery stenosis, surgical treatment
carotid artery stenosis, symptomatic
cerebral atherosclerosis
cerebral atherosclerosis, medical management
cerebral embolism
cerebral embolism, cardiac origin
cerebral infarction
cerebral infarction, small, deep
cerebral ischemia
cerebrovascular accident
cerebrovascular accident, acute management of
cerebrovascular accident, infancy and childhood
cerebrovascular accident, model for predicting risk of
cerebrovascular accident, platelet inhibiting drugs in treatment
cerebrovascular accident, prevention of
cerebrovascular accident, primary prevention
cerebrovascular accident, racial differences
cerebrovascular accident, recurrent
cerebrovascular accident, secondary prevention
cerebrovascular accident, thrombolytic agents in treatment
cerebrovascular accident, time to treatment
cerebrovascular accident, women
cerebrovascular accident, work up for
cerebrovascular disease
cerebrovascular disease, risk factors in
cerebrovascular disease, surgical treatment of
cerebrovascular disease, treatment of
CHADS2
CHANCE Trial
CHARISMA
children
cholesterol
cilostazol
clopidogrel
coma
compliance
complications
confusion
contraindications
controversies in neurology
coronary artery disease
cost effectiveness
coumadin, eligibility for
coumarin
craniectomy, decompressive
dabigatran
decision analysis
dementia
diabetes mellitus
diarrhea
dilantin
dilantin, factors influencing metabolism of
dilantin, toxicity
dipyridamole
disorientation
drug interactions
efficacy
embolism, silent
emergencies, medical
emergencies, neurologic
endarterectomy, carotid
endarterectomy, carotid-complications of
endarterectomy, carotid-indications for
endovascular therapy
epidemiology of neurology
erythroderma
evidence-based research
factor Xa inhibitor
fever
fibrinolytic agents
fibrinolytic agents, complications
gastrointestinal bleeding
gender
genetic testing
headache
headache, drug induced
health care reform
hematoma, epidural-spinal
hemophilia
hemorrhagic diathesis
hemorrhoidectomy
hemorrhoids
heparin
hypercholesterolemia
hypertension
iatrogenic neurologic disorders
INR values
intellectual deterioration
intracerebral hemorrhage
intracerebral hemorrhage, treatment of
intracranial hemorrhage
Irbesartan
jaundice
lacunar infarction
leukopenia
liver function enzymes
lumbar puncture
lumbar puncture, complications of
malformation, vascular
malformation, vascular, cerebral
malformation, vascular, treatment of
malpractice
MATCH trial
medical-legal aspects of neurology
memory, impairment of
microangiopathic hemolytic anemia
middle cerebral artery atherosclerosis
migraine
misdiagnosis
mortality
MRI, abnormal
MRI, angiography
MRI, diffusion weighted
MRI, timing after stroke
multimodal neuroimaging
myocardial infarction
myocardial infarction, acute
nausea and vomiting
neurologic disease, diagnoses of
neurologic symptoms
neutropenia
old age, neurology of
omeprazole
outcome research
PFA-100
plasmapheresis
platelet function test
platelet inhibiting drugs
platelet inhibiting drugs, combined
platelet inhibiting drugs, discontinuation
platelet transfusion
POINT trial
practice guidelines
prevention of neurologic disorders
PROFESS trial
prognosis
proton pump inhibitors
race
rash
renal failure
review article
risk factors
risk factors, modification
risk-benefit assessment
rivaroxaban
safety
screening
seizure
seizure, psychomotor-temporal lobe
slurred speech
statin therapy
stroke, progression of
subarachnoid hemorrhage
subarachnoid hemorrhage, treatment of
symptomatic
temporal lobe, status
thrombin inhibitor
thrombocytopenia
thrombotic thrombocytopenia purpura
ticagrelor
ticlopidine
tissue plasminogen activator, intravenous
transient ischemic attack
transient ischemic attack, etiology of
transient ischemic attack, evaluation
transient ischemic attack, treatment of
transluminal angioplasty, intracranial
treatment of neurologic disorder
vertebral-basilar artery, atherosclerosis
vitamin K antagonist
workup
Showing articles 50 to 88 of 88 << Previous

Cost-Effectiveness of New Antiplatelet Regimens Used as Secondary Prevention of Stroke or Transient Ischemic Attack
Arch Int Med 160:2773-2778, Sarasin,F.P.,et al, 2000

Thrombotic Thrombocytopenic Purpura Associated with Ticlopidine Use,A Report of 3 Cases and Review of the Literature
Arch Int Med 159:311-314, Chen,D.K.,et al,, 1999

Secondary Prevention after Cerebral Ischaemia of Presumed Arterial Origin:Is Aspirin Still the Touchstone?
JNNP 66:557-559, Algra,A.,et al, 1999

Antiplatelet Therapy in Acute Cerebral Ischemia
Stroke 30:887-893, Bednar,M.M.&Gross,C.E., 1999

Toxic Erythroderma Due to Ticlopidine
NEJM 340:1212, Hsi,D.H.,et al, 1999

Therapeutic Benefit, Aspirin Revisited in Light of the Introduction of Clopidogrel
Stroke 30:1716-1721, Gorelick,P.B.,et al, 1999

Antiplatelet Therapy:Views from the Experts
Neurol 53:S32-S37, Easton,J.D.,et al, 1999

Thrombotic Thrombocytopenic Purpura Assoc with Ticlopidine, Review of 10 Cases
Ann Int Med 128:541-544, Bennett,C.L.,et al, 1998

Clopidogrel for Reduction of Atherosclerotic Events
The Medical Letter 40:59-60, , 1998

The Antiplatelet Effects of Ticlopidine and Clopidogrel
Ann Int Med 129:394-405, Sharis,P.J.,et al, 1998

Ticlopidine and Thrombotic Thrombocytopenic Purpura
NEJM 337:1245, Kupfer,Y.&Tessler,S., 1997

Aplastic Anemia Associated with Ticlopidine
Neurol 47:300, Shapiro,C.M.&Walk,D., 1996

Ticlopidine Impairs Phenytoin Clearance:A Case Report
Neurol 46:1172-1173, Riva,R.,et al, 1996

A Randomised
Blinded Trial of Clopidogrel vs. Aspirin in Patients at Risk of Ischaemic Events (CAPRIE) , CAPRIE S, eerimte,Lancet 348:1329-1339,1996., 1996

Acute Phenytoin Toxicity Followed by Seizure Breakthrough From a Ticlopidine-Phenytoin Interaction
Arch Neurol 53:1191-1192, Privitera,M.&Welty,T.E., 1996

Stroke Prevention Therapies and Management of Patient Subgroups
Neurol 45:S19-S24, Raps,E.C.&Galetta,S.L., 1995

Drugs and Surgery in the Prevention of Ischemic Stroke
NEJM 332:238-248, Barnett,H.J.M.,et al, 1995

Compliance with Antiplatelet Therapy in Pts with Ischemic CVD:Assessment by Platelet Aggregation Testing
Stroke 25:2337-2342, Komiya,T.,et al, 1994

Stroke:The Way Things Really Are
Stroke 25:1290-1294, Scheinberg,P., 1994

Medical Treatment for Stroke Prevention
Ann Int Med 121:41-55, Matchar,D.B.,et al, 1994

Cost-Effectiveness of Ticlopidine in Preventing Stroke in High-Risk Patients
Stroke 25:1149-1156, 10971994., Oster,G.,et al, 1994

Guidelines for the Management of Transient Ischemic Attacks
Stroke 25:1320-1335, Feinberg,W.M.,et al, 1994

The Efficacy & Safety of Ticlopidine & Aspirin in Non-Whites:Subgroup from Ticlopidine Aspirin Stroke Study
Neurol 43:27-31, Weisberg,L.A., 1993

Efficacy of Ticlopidine & Aspirin for Prev of Rev Cerebrovascular Ischemic Events, Ticlopidine Aspirin Study
Stroke 24:1452-1457, Bellavance,A.,et al, 1993

Role of Ticlopidine for Prevention of Stroke
Stroke 23:912-916, Albers,G.W., 1992

Ticlopidine for Prevention of Stroke
The Medical Letter, 34:65-661992., , 1992

A Critical Appraisal of Ticlopidine, A New Antiplat Agent, Effectiveness & Clin Indic for Prophylaxis
Arch Int Med 152:1376-1380, Haynes,R.B.,et al, 1992

Ticlopidine vs Aspirin for Prevention of Recurrent Stroke, Analysis of Pts with Stroke from Ticlopidine Aspirin Study
Stroke 23:1723-1727, Harbison,J.W., 1992

Prevention of Stroke with Ticlopidine:Who Benefits Most?
Neurol 42:111-115, Grotta,J.C.,et al, 1992

Antithrombotic Therapy in Cerebrovascular Disease
Ann Int Med 115:885-895, Rothrock,J.F.&Hart,R.G., 1991

Ticlopidine
Editorial, Lancet 337:459-4601991., , 1991

Thrombotic Thrombocytopenic Purpura Related to Ticlopidine
Lancet 337:774-776, Page,Y.,et al, 1991

Stroke Prevention in Women:role of Aspirin Versus Ticlopidine
Am J Med 91:288-292, Hershey,L.A., 1991

Ticlopidine, A New Antithrombotic Drug:But Is It Better than Aspirin for Longterm Use?
JNNP 53:185-187, Warlow,C., 1990

Ticlopidine and Thrombocytopenia
NEJM 323:1487-1489, Takishita,S.,et al, 1990

The Canadian American Ticlopidine Study (CATS) in Thromboembolic Stroke
Lancet 1:1215-1220, Gent,M.,et al, 1989

A Randomized Trial Comparing Ticlopidine Hydrochloride with Aspirin for the Prevention of Stroke in High-Risk Patients
NEJM 321:501-507, Hass,W.H.,et al, 1989

Combination Therapy with Low-Dose Aspirin and Ticlopidine in Cerebral Ischemia
Stroke 20:1643-1647, Uchiyama,S.,et al, 1989

Current Medical & Surgical Therapy for Cerebrovascular Disease
NEJM 317:1505-1516, Grotta,J.C., 1987



Showing articles 50 to 88 of 88 << Previous